Core Insights - Viatris Inc. (NASDAQ: VTRS) is recognized as one of the 13 Best March Dividend Stocks to Buy [1] - UBS has raised its price target for Viatris from $18 to $20, maintaining a Buy rating, citing the company's achievement of Q4 cost-saving goals and positive FY26 guidance [2] - The company reported total revenue of $14.3 billion and adjusted EBITDA of $4.2 billion for Q4 2025, indicating strong financial performance [3] Financial Performance - Viatris achieved total revenue of $14.3 billion and adjusted EBITDA of $4.2 billion in Q4 2025, reflecting the overall strength of the business [3] - The company returned over $1 billion to shareholders through dividends and share repurchases during the year [4] Growth Outlook - Viatris expects to generate approximately $650 million in gross cost savings over three years, with up to $250 million reinvested into growth initiatives [5] - The company is preparing for a potential FDA reinspection of its Indore facility, implementing operational redundancies to ensure continuity and stability [5] Pipeline Progress - Five Phase III studies have delivered positive results, marking an important milestone for the company [4] - Enrollment in key programs, including cenerimod and selatogrel, is progressing and expected to be completed in 2026 [4] Strategic Initiatives - The completion of 60 regional transactions, including the acquisition of Aculys Pharma in Japan, is part of Viatris' broader strategic plan [4]

UBS plans to keep Ermotti on as CEO for longer, NZZ reports | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Sergio P. Ermotti, CEO attends the Annual General meeting of Swiss bank UBS in Lucerne, Switzerland, April 10, 2025. REUTERS/Denis Balibouse/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Hanna Capital Corp]Follow[UBS Group AG]FollowVIENNA, Feb 28 (Reuters) - The board of directors of Swiss banking giant UBS ...

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv British Airways owner IAG beats annual profit estimates February 27, 20267:09 AM UTCUpdated ago By Reuters A scale model of an aircraft with British Airways livery is seen at the British Airways headquarters and IAG head office in Harmondsworth, London, Britain, March 13, 2025. REUTERS/Toby... Purchase Licensing Rights, opens new tab Read more Feb 26 (Reuters) - British Airways owner IAG (ICAG ...

Yahoo Finance reported that JPMorgan Chase & Co. (NYSE:JPM) CEO Jamie Dimon warned on February 23 that the financial environment feels similar to the years before the global financial crisis.Speaking at the company’s annual investor day in New York, Dimon said: “Unfortunately, we did see this in ’05, ’06, ’07, almost the same thing. The rising tide lifting all boats, everyone was making a lot of money, people leveraging to the hilt. The sky was the limit.”These comments by Dimon come during a volatile time ...

Group 1 - UBS has one item remaining in the migration of former Credit Suisse clients onto UBS's system [1]

Exelon Corporation (NASDAQ:EXC) is among the 15 Best Electric Utility Stocks to Invest In Now. Morgan Stanley Keeps an Equal Weight Rating on Exelon Corporation (EXC) Exelon Corporation (NASDAQ:EXC) is among the Best Utility Stocks.   On February 20, 2026, Morgan Stanley boosted Exelon Corporation (NASDAQ:EXC)’s price objective to $54 from $51, maintaining an Equal Weight rating. The firm increased its price predictions for North American Regulated and Diversified Utilities and IPPs. Morgan Stanley note ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. A WallStreetBets trader drew attention after posting a screenshot showing a massive win on gold-linked options, turning low-cost calls on the SPDR Gold Shares ETF (NYSE:GLD) into more than $51,000. The position, which the trader called "Getting My Shiny Rocks Off," shows 40 call contracts purchased at an average cost of $4.01 and later valued at $13.51, producing a gain of more than $35,000, or roughly 220 ...

A WallStreetBets trader drew attention after posting a screenshot showing a massive win on gold-linked options, turning low-cost calls on the SPDR Gold Shares ETF (NYSE:GLD) into more than $51,000.The position, which the trader called "Getting My Shiny Rocks Off," shows 40 call contracts purchased at an average cost of $4.01 and later valued at $13.51, producing a gain of more than $35,000, or roughly 220%.In the comments, one user summed up the bullish mood, saying, "Anyone not buying and holding gold thro ...

Core Viewpoint - International Business Machines Corporation (IBM) is facing significant challenges due to advancements in AI technology that could impact its legacy systems and business model, particularly in relation to COBOL programming [3][4][6]. Group 1: Stock Performance and Analyst Ratings - UBS upgraded IBM from Sell to Neutral with a price target of $236, indicating a more balanced outlook following recent stock volatility [2]. - On February 23, IBM shares experienced a notable decline of approximately 13.2%, closing at $223.35, primarily due to concerns raised by Anthropic's announcement of its Claude Code AI tool [3]. Group 2: Impact of AI on Legacy Systems - IBM has historically supported COBOL-based systems, which are critical for various operations such as banking and retail [4]. - The introduction of AI tools like Anthropic's Claude Code can automate the modernization of COBOL code, which has traditionally been a complex and costly process [5]. - The decline in the number of COBOL programmers has made AI tools increasingly valuable, as they can expedite the analysis and updating of large codebases [5]. Group 3: Broader Industry Concerns - The developments surrounding AI have raised broader concerns among investors regarding its potential impact on established technology companies, including IBM [6]. - IBM operates in the hybrid cloud, AI, and consulting sectors, with its business divided into four main segments: Software, Consulting, Infrastructure, and Financing [6].

FactSet Research Systems Inc. (NYSE:FDS) is included among the 13 Most Promising Long-Term Stocks to Buy According to Hedge Funds. FactSet (FDS) Faces Price Target Cut from Barclays on Market Data Industry Concerns Photo by Jp Valery on Unsplash On February 23, Barclays lowered its price recommendation on FactSet Research Systems Inc. (NYSE:FDS) to $210 from $300. The firm maintained an Underweight rating on the shares. In its research note, Barclays said AI has “exacerbated investor concerns around wha ...